drugset / Trial / NCT07856680

Clinical Lid Eradication of Antifungal-Responsive FUNGUS Study

NCT07856680 ↗

Phase 4 Not yet recruiting 60 enrolled Brent Kramer
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to learn if Natacyn works to reduce or eliminate laboratory-confirmed fungal organisms in subjects with fungal-positive blepharitis identified in a previous study. asthma in adults. It will also learn more about the safety of Natacyn. The main questions it aims to answer are: Does Natacyn reduce or eliminate fungal presence? Does Natacyn cause a reduction in eye irritation and itchiness? What medical problems do participants have when using Natacyn? Participants will: Apply Natacyn 4 times a day for 21 days Visit the clinic once every week for checkups and tests Keep a diary of the number of times they apply Natacyn over the 21-day period

Timeline

Start
2026-10
Primary completion
2027-03
Completion
2027-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Natamycin Small molecule 5 % Topical

Indications